PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
32058829-0	2021	UVR-B-induced NKR-1 Expression in Ocular Tissues is blocked by Substance P Receptor Antagonist Fosaprepitant in the Exposed as well as Unexposed Partner Eye.	fosaprepitant	95-108	tachykinin receptor 1	Mus musculus	63-83
33729475-13	2021	Conclusions: Topical administration of the NK1R antagonist fosaprepitant effectively reduces ocular surface nociception by decreasing SP release in the tear fluid and TG, and corneal leukocyte infiltration.	fosaprepitant	59-72	tachykinin receptor 1	Mus musculus	43-47
33729475-13	2021	Conclusions: Topical administration of the NK1R antagonist fosaprepitant effectively reduces ocular surface nociception by decreasing SP release in the tear fluid and TG, and corneal leukocyte infiltration.	fosaprepitant	59-72	trefoil factor 2 (spasmolytic protein 1)	Mus musculus	134-136
27510503-1	2016	Intravenous fosaprepitant dimeglumine (Emend( ) for injection, IVEmend( ); henceforth referred to as fosaprepitant) is a prodrug of and is rapidly converted to the antiemetic aprepitant, and is approved in several countries worldwide (as part of an antiemetic regimen) for the prevention of nausea and vomiting associated with highly and moderately emetogenic chemotherapy (HEC and MEC).	fosaprepitant	63-70	C-C motif chemokine ligand 28	Homo sapiens	382-385